1. Türkistanlı EC, Soğukpınar N, Saydam BK, Aydemir G. Cervical cancer prevention and early detection-the role of nurses and midwives. Acian Pac J Cancer Prev 2003; 4(1): 15-21.
2. Soler ME, Gaffikin L, Blumenthal PD. Cervical cancer screening in developing countries. Prim. Care Update Ob Gyns 2000; 7(3): 118-23
3. American Cancer Society. Cancer facts and figures, 2002. Atlanta: American Cancer Society, 2002.
4. National Statistics. Cancer registrations in England, 2000.
5.
Jinekoloji
k muayene. Propedötik Kadın Doğum. Ed Arısan K. 2. baskı , İstanbul, Nobel Tıp Kitapevleri Ltd Şti. 1997; 187-251.
6. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Cervical Cytology screening. Number 45, August 2003. Int J Gynaecol Obstet 2003; 83(2): 237-47.
7. Kavak ZN, Eren F, Pekin S, Kullu S. A randomized comparison of the 3 Papanicolaou smear collection methods. Aust N Z J Obstet Gynaecol 1995; 35(4): 446-9.
8. Buntinx F, Brouwers M. Relation between sampling device and detecti¬on of abnormality in cervical smears: a meta-analysis of randomised and quasi-randomised studies. BMJ 1996; 313: 1285-90.
9. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C. American Cancer Society guideline for the early de¬tection of cervical neoplasia and cancer. CA Cancer J Clin 2002; 52:
342-62.
10. Ressel GW. Practice guidelines: ACOG releases guidelines on cervical cytology screening. Am Family Physician 2003; 68: 2081.
11. Apgar BS, Zoschnick L, Wright TC Jr. The 2001 Bethesda System ter¬minology. Am Fam Physician 2003; 68(10): 1992-8.
12. Berek JS. Simplification of the new Bethesda 2001 classification system. Am J Obstet Gynecol 2003; 188(3 suppl): S 2-5.
13. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001
Consensus Guidelines for the management of women with cervical cyto-
logical abnormalities. JAMA 2002; 287(16): 2120-9.
14. Preinvazive disease of the cervix. Clinical Gynecologic Oncology Ed. Disaia AJ, Creasman WT. 6. baskı, Mosby inc. 2002; 1-33.
15. Veljovich DS, Stoler MH, Andersen WA, Covel JL, Rice LW. Aty¬pical glanduler cells of undetermined significance:A five year retrospec¬tive histopathologic study. Am J Obstet Gynecol 1998; 179: 382-90.
16. US Preventive Services Task Force. Recommendations and Rationale,Screening for Cervical Cancer 2003 (www.ahrq.gov/clinic/ 3rduspstf/cervcan/cervcanrr.htm'den ulaşılabilir.)
17.
Karabaca
k T, Aydın Ö, Düşmez D, Polat A, Cinel L, Eğilmez R. Ser-vikovajinal smearlerde sınırlılık/yetersizlik oranları ve nedenleri (2832 olgu). Patoloji Bülteni 2001; 18(3): 22-5.
18. McNeeley SG. New cervical cancer screening techniques. Am J Obstet
Gynecol 2003; 189(4): S 40-1.
19.
Kös
e MF. Jinekolojide human papilloma virus enfeksiyonlarının yeri. MN-Klinik Bilimler & Doktor 2002; 8(1): 122-8.
20. Nuovo J. New tests for cervical cancer screening. Am Fam Physician
2001; 64(5): 780-6.
21. Özçelik B, Serin IS, Gökahmetoğlu S, Başbuğ M, Erez R. Human papilloma virus frequency of women at low risk of developing cervical cancer : a preliminary study from a Turkish university hospital. Eur J
Gynaecol Oncol 2003; 24(2): 157-9.
Türkiye Aile Hekimliği Dergisi | Turkish Journal of Family Practice | Cilt 8 | Sayı 3 | 2 0 0 4 | 109
22. Pekin T. Servikal intraepitelyal lezyonların tanı ve tedavilerinde, pap smear ile human papillomavirus (HPV) testlerinin kombinasyonunun önemi. T Klin Jinekol Obst 2002; 12(2): 203-7.
23. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society. American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin 2004; 54(1): 41-52.
Thank you for copying data from http://www.arastirmax.com
